Blood Flow Mismatch in Pancreatic Cancers Winston Salem NC

Finnish researchers say they have identified a blood-flow metabolism mismatch that predicts pancreatic cancer aggressiveness. The investigators used a three-dimensional imaging technique called positron emission tomography (PET) to measure blood flow and glucose consumption -- a measure of general metabolic activity of a tissue -- in 26 people.

Yi-Kong Keung
(336) 716-2255
Medical Center Blvd
Winston Salem, NC
Specialty
Medical Oncology

Data Provided by:
Eugene Paschold
(336) 277-8800
1010 Bethesda Ct
Winston Salem, NC
Specialty
Hematology / Oncology

Data Provided by:
Glenn J Lesser
(336) 716-2255
Medical Center Blvd
Winston Salem, NC
Specialty
Internal Medicine, Medical Oncology

Data Provided by:
Kathryn M Greven, MD
(336) 713-3600
Medical Center Blvd,
Winston Salem, NC
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Female
Education
Medical School: Bowman Gray Sch Of Med Of Wake Forest Univ, Winston-Salem Nc 27157
Graduation Year: 1983
Hospital
Hospital: Wake Forest Baptist Med Ctr, Winston Salem, Nc
Group Practice: Wake Forest Univ Baptist Med

Data Provided by:
Mohan Chand Thakuri, MD
(336) 716-5257
Watlington Hall 1st Fl Medcl Ctr Blvd,
Winston Salem, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Tribhuvan Univ, Inst Of Med, Kathmandu, Nepal
Graduation Year: 1991

Data Provided by:
Richard Alan Brodkin, MD
(336) 277-8800
1010 Bethesda Ct
Winston Salem, NC
Specialties
Oncology (Cancer), Hematology-Internal Medicine
Gender
Male
Education
Medical School: Bowman Gray Sch Of Med Of Wake Forest Univ, Winston-Salem Nc 27157
Graduation Year: 1974
Hospital
Hospital: Forsyth Mem Hosp, Winston Salem, Nc
Group Practice: Piedmont Hematology Oncology Associates

Data Provided by:
Richard A Brodkin
(336) 277-8800
1010 Bethesda Ct
Winston Salem, NC
Specialty
Hematology / Oncology

Data Provided by:
Steven Alan Akman, MD
(336) 716-0230
Medical Center Blvd,
Winston Salem, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: A Einstein Coll Of Med Of Yeshiva Univ, Bronx Ny 10461
Graduation Year: 1975

Data Provided by:
Allen Russell Chauvenet, MD
Winston Salem, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Univ Of Fl Coll Of Med, Gainesville Fl 32610
Graduation Year: 1978

Data Provided by:
Nick George Chrysson
(336) 277-8800
1010 Bethesda Ct
Winston Salem, NC
Specialty
Hematology / Oncology

Data Provided by:
Data Provided by:

Blood Flow Mismatch in Pancreatic Cancers

Provided By:

WEDNESDAY, Aug. 26 (HealthDay News) -- Finnish researchers say they have identified a blood-flow metabolism mismatch that predicts pancreatic cancer aggressiveness.

The investigators used a three-dimensional imaging technique called positron emission tomography (PET) to measure blood flow and glucose consumption -- a measure of general metabolic activity of a tissue -- in 26 people. The researchers noted that blood flow in malignant tumors was 60 percent less than in normal pancreatic tissue.

The findings may help explain why many pancreatic cancer patients have a poor response to radiation treatment and chemotherapy, the study authors noted in their report published Aug. 25 in Clinical Cancer Research.

"Imaging of several of these tumor parameters might be important for the planning and success of [cancer] therapies," study author Dr. Gaber Komar, research fellow at the Turku PET Center, said in a news release from the American Association for Cancer Research. "We believe that a better understanding of these mechanisms may help overcome the general treatment resistance of pancreatic cancer."

"This study confirms that blood flow metabolism mismatch exists in pancreatic tumors, similar to other cancers such as breast and lung cancers, and predicts poor patient outcome," Dr. David Mankoff, a professor of radiology, medicine and bioengineering at the University of Washington in Seattle, said in the news release.

"A blood flow metabolism mismatch by PET appears to be associated with cancer aggressiveness and treatment resistance. We've only recently recognized this pattern as a result of advantages in functional imaging methods," added Mankoff.

More information

The American Cancer Society has more about pancreatic cancer.

SOURCE: American Association for Cancer Research, news release, Aug. 25, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com